Impact of thyroid immune-related adverse events on clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with checkpoint inhibitor therapy: A single center study

Impact of thyroid immune-related adverse events on clinical outcomes in non-small cell lung cancer (NSCLC) patients treated with checkpoint inhibitor therapy: A single center study

Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for non-small cell lung carcinoma (NSCLC) but are associated with immune-related adverse events (irAEs), including thyroid dysfunction. This study examines the incidence and clinical impact of thyroid dysfunction in NSCLC...

Full description

Saved in:
Bibliographic Details
Main Authors: Šejla Cerić, Timur Cerić, Emir Sokolović, Jasmina Dalač, Dragana Miletić, Inga Marijanović, Layan Mattar, Amina Aljić, Selma Agić-Bilalagić, Amera Šadija, Miran Hadžiahmetović, Semir Bešlija
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2025-03-01
Series:Biomolecules & Biomedicine
Subjects:
Non-small cell lung cancer
NSCLC
immunotherapy
immune checkpoint inhibitors
ICIs
thyroid dysfunction
Online Access:http://www.bjbms.org/ojs/index.php/bjbms/article/view/12321
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.bjbms.org/ojs/index.php/bjbms/article/view/12321

Similar Items